Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/ard-2022-222441
Abstract: Objectives In dermatomyositis (DM), autoantibodies are associated with unique clinical phenotypes. For example, anti-TIF1γ autoantibodies are associated with an increased risk of cancer. The purpose of this study was to discover novel DM autoantibodies. Methods… read more here.
Keywords: tif1 positive; anti sp4; sp4 autoantibodies; anti tif1 ... See more keywords
Characteristics of anti-transcriptional intermediary factor 1 gamma autoantibody-positive dermatomyositis patients in Singapore.
Sign Up to like & getrecommendations! Published in 2022 at "Annals of the Academy of Medicine, Singapore"
DOI: 10.47102/annals-acadmedsg.2022278
Abstract: INTRODUCTION This study aimed to determine the clinical profile and outcome of anti-transcriptional intermediary factor 1 gamma autoantibody (anti-TIF1-γ Ab)-positive dermatomyositis patients and propose cancer screening programmes based on regional cancer trends. METHOD Data on… read more here.
Keywords: tif1 positive; anti transcriptional; positive dermatomyositis; dermatomyositis patients ... See more keywords